Myricetin exposure reduces PC differentiation in vitro in primary human B cells
Abstract Background The process of B cell activation and plasma cell (PC) formation involves morphological, transcriptional, and metabolic changes in the B cell. Blocking or reducing PC differentiation is one approach to treat autoimmune diseases that are characterized by the presence of pathogenic...
Saved in:
| Main Authors: | Shabirul Haque, Betty Diamond |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s10020-025-01068-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioanalytical assay for the quantification of rucaparib in rat plasma using UPLC-MS/MS: development, and validation for interaction with myricetin
by: Jingjing Nie, et al.
Published: (2025-05-01) -
Myricetin Restricts the Syncytial Development Triggered by Nipah Virus Envelope Glycoproteins In Vitro
by: Ananda Murali Rayapati, et al.
Published: (2025-06-01) -
Myricetin inhibits Micropterus salmoides rhabdovirus infection by damping inflammation through the NF-κB pathway
by: Zhiwen Wang, et al.
Published: (2025-03-01) -
A Novel Temozolomide-Myricetin Drug-Drug Cocrystal: Preparation, Characterization, Property Evaluations
by: Hai-Xin Qin, et al.
Published: (2025-07-01) -
Myricetin protects mice against colitis by activating aryl hydrocarbon receptor signaling pathway
by: Tao Xu, et al.
Published: (2025-01-01)